GDF2 and breast cancer: In a previous study, our results showed that BMP9 inhibited the growth, migration, and invasion of highly malignant MDA-MB-231 and HER2-positive SK-BR-3 cells [22–24], and suppressed the epithelial-mesenchymal transition (EMT) of breast cancer cells in the bone microenvironment [25].